IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G - Wikidata - wikimedia - TriplyDB

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

http://www.wikidata.org/entity/Q24633495

about

The immune pathogenesis of scleroderma: context is everything The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particles Inhibitors of Serine Proteases in Regulating the Production and Function of Neutrophil Extracellular Traps Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung Lung inflammation caused by inhaled toxicants: a review Cytokine-Induced Modulation of Colorectal Cancer The IL-1 cytokine family and its role in inflammation and fibrosis in the lung Innate Immunity and Biomaterials at the Nexus: Friends or Foes Re-defining the unique roles for eosinophils in allergic respiratory inflammation Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice Group 2 innate lymphoid cells: new players in human allergic diseases Inflammasomes in pancreatic physiology and disease Structural insights into the interaction of IL-33 with its receptors MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis Dealing with Danger in the CNS: The Response of the Immune System to Injury.Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy.Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells.Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients.Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions.Full Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction.Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis Interleukin 33: a switch-hitting cytokine.Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity Deubiquitination and stabilization of IL-33 by USP21.The interleukin-1 family: back to the future Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice.IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice Cytokine profile in a cohort of healthy blood donors carrying polymorphisms in genes encoding the NLRP3 inflammasome.Rhinovirus and asthma: a storied history of incompatibility.Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin.At the bench: understanding group 2 innate lymphoid cells in disease.AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites.A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.

P2860

Q24633658-FDFCEC03-54A5-4888-A797-6B78636E9A22 Q26741584-9B7BA853-CF67-42E0-A534-5C07D86CA74B Q26742159-543F40C7-7661-45A5-8FD6-98BB3DB8CC86 Q26742160-BC6C1908-0D3E-40D8-95B7-7E9AEAC8BF5C Q26744356-7FAFF3E0-9A87-4C8E-83D0-71D5EFC94FBD Q26752374-1272065E-F946-4646-80AA-35CB1C5AB5BA Q26752849-3727484E-472B-440C-8A49-D4E9481B7B7A Q26801604-3590D1F3-B8ED-4AF4-8E9B-CE1A06FB74AA Q26828515-EB11C935-C1A7-4B89-806F-2BE49DA53CF3 Q26992101-4EC2959E-C53C-4268-9C33-270FE7F5884D Q27008536-1486EAA0-9712-4FD1-8F63-06CE6960C7A3 Q27021604-B5151618-F39E-461D-82CB-3F3A0CD08C1D Q27027483-66414F9C-302F-4E5C-9125-111D1575ABED Q27679811-3709EDD4-F21B-437F-A70A-5CCCEB0C6EB4 Q28260209-01CE80D1-805A-4503-8184-38A124618AF7 Q28388782-87EDF0AC-5BAA-484E-BF2F-5E6023F7C77A Q30279070-8D9E34FF-01D4-45ED-8DA0-E3255C249F43 Q30359565-2D522B7D-E6B4-4723-A552-DCB52BB2D82D Q30577312-A92844D1-B77C-46A9-9656-13354CA041E9 Q33593742-09F805EE-3E41-4E42-AD6E-3A4990891ED6 Q33604481-AB05EBA6-54A2-4D59-A034-86F9F0D6CD65 Q33758290-80DF64D2-5409-4D2D-9B6D-56A756D82850 Q33760241-82DFD2B6-8B83-4D6A-9D99-40687CAB9ABC Q33778540-2C880A86-C0AE-455E-A1BF-F69CC486D6D1 Q33843062-D6AF7B32-BDD5-4E0B-9B54-0FDCAA0F7B41 Q33855694-468A2341-7250-4C08-A540-A16222C306EA Q33987547-5A7BB205-316D-45C0-A676-DD659AC1D41C Q34033407-E301FC46-9A5A-4EA4-A56B-7DA2F703B304 Q34121429-798A6563-26AF-4419-BBA6-A1C704C2AB2F Q34391415-003FF401-F716-40D1-8D16-EC16EFD3268E Q34442444-93E8731A-E7D5-4EF5-9C38-F516798BC54A Q34493943-14611E57-0EF5-4E35-8DC0-E675B195E33C Q34590317-AE98A1F8-6949-4044-8992-2A88F957B327 Q34647885-A0ACC08B-9694-4D2C-8C02-32F69C197E60 Q35009123-9AD61D08-B7E4-4AFA-A772-88D218EBE492 Q35082562-5C3EE41D-B01D-440C-8146-03399D7DA22B Q35105619-B24582DB-3604-48B8-854F-74B319B585E7 Q35115465-0E81BDFE-F14F-4EA3-B177-A39F557AA8FF Q35699580-43BFE039-FE94-4CB9-9FB8-74D19F23D24E Q35724182-6F7BADA6-4C4D-4940-809C-84D99377905D

P2860

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

http://www.wikidata.org/entity/Q24633495

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@ast

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@en

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@nl

type

label

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@ast

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@en

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@nl

prefLabel

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@ast

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@en

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@nl

P1433

Q24633495-13A3C757-6443-40FB-B7B3-8DF180DB3BA2

P1476

Q24633495-5900E6EE-2CAA-4AF7-B31E-2D4E7C559EDC

P2093

Q24633495-B6D25684-D4FC-4EF8-9273-51A743E454AD

Q24633495-D1996ACF-D132-4DE3-9655-CB12E02BC81A

Q24633495-D845F602-BB11-4608-91A9-916FA5D1B90B

Q24633495-E7619B11-9128-46FD-A10C-3EA0F21EC079

Q24633495-FD661BC7-D8E7-47E1-B088-A7A1A324821C

P2860

Q24633495-05EA3303-6DF8-494F-AA65-2A0B62C0CEBD

Q24633495-07452A5B-4DA5-4211-A069-A258C7D1840B

Q24633495-0EBC9E67-E593-4224-A928-4CAFBD58A9B1

Q24633495-16452EBA-1001-4336-99F3-C95CA3B89F64

Q24633495-2062B838-FCBF-4CB2-868A-3BA72EAF6501

Q24633495-20F267BC-2370-4664-B3FA-18679DEFE1B2

Q24633495-2100E586-A0ED-465C-85BC-C617EE716D03

Q24633495-2159D844-01AD-46D8-876A-0661107F9AC5

Q24633495-2D55F674-CF5D-49F5-980C-C0A18D41B422

Q24633495-3072A25B-64F5-401E-A06C-A52EF089EA94

P304

Q24633495-3415C426-D34D-40AF-81D7-8603065D20C9

P31

Q24633495-AFC2514F-4D07-4BE1-BAAF-4C5ADD8FB42A

P3181

Q24633495-5CA8A28C-F0B0-4003-BBED-790FA6FFE695

P356

Q24633495-55496779-F46C-4E3D-93F5-F532246FBE2F

P407

Q24633495-DD407EAD-6906-43B1-B7D0-39ABFB9475D2

P433

Q24633495-2DD49C61-F3F0-4900-A60E-4F05A0FB861D

P478

Q24633495-7566EF64-DAFD-4D4A-8A0A-B8561224BBC6

P50

Q24633495-3DA3B30E-88E3-4921-AFC8-AB999BE418BE

Q24633495-91D15958-D9E1-428E-91C0-EB0BD8A8054F

P577

Q24633495-73FC67D9-19D0-49E6-A7C2-D19D53EB0119

P5875

Q24633495-77656D7C-22E7-4929-8EAD-9D69AECEF4B3

P698

Q24633495-9E8015C6-11ED-4F63-A48F-523FE1897E76

P932

Q24633495-0D3E1CCC-B58E-470A-95BE-A74C9C06F02C

P3181

P356

PNAS.1115884109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

@en

P2093

Bernard Monsarrat

http://www.w3.org/2001/XMLSchema#string

Emma Lefrançais

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Girard

http://www.w3.org/2001/XMLSchema#string

Stephane Roga

http://www.w3.org/2001/XMLSchema#string

Violette Gautier

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

P304

1673-1678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

369020

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1115884109

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Anne Gonzalez de Peredo

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221808149

http://www.w3.org/2001/XMLSchema#string

P698

22307629

http://www.w3.org/2001/XMLSchema#string

P932

3277172

http://www.w3.org/2001/XMLSchema#string